Schall Law Firm Investigates iTonic Holdings Shareholder Rights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 29 2026
0mins
Should l Buy ITOC?
Source: Globenewswire
- Investigation Launched: The Schall Law Firm has announced an investigation into iTonic Holdings Ltd. to determine if the company violated securities laws, focusing on potential false or misleading statements that could affect investor rights.
- Investor Losses Addressed: This investigation aims to protect shareholders who may have suffered losses due to iTonic's alleged misconduct, highlighting the firm's commitment to safeguarding shareholder interests.
- Legal Services Offered: Schall Law Firm provides free consultations to help shareholders understand their rights, further enhancing its professional image and market influence in the securities class action space.
- Global Investor Representation: The firm specializes in securities class actions and represents investors worldwide, demonstrating its extensive influence and expertise in protecting investor rights.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ITOC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ITOC
Wall Street analysts forecast ITOC stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 0.340
Low
Averages
High
Current: 0.340
Low
Averages
High

No data
About ITOC
Pheton Holdings Ltd is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Investigation Launched: The Schall Law Firm has announced an investigation into iTonic Holdings Ltd. to determine if the company violated securities laws, focusing on potential false or misleading statements that could affect investor rights.
- Investor Losses Addressed: This investigation aims to protect shareholders who may have suffered losses due to iTonic's alleged misconduct, highlighting the firm's commitment to safeguarding shareholder interests.
- Legal Services Offered: Schall Law Firm provides free consultations to help shareholders understand their rights, further enhancing its professional image and market influence in the securities class action space.
- Global Investor Representation: The firm specializes in securities class actions and represents investors worldwide, demonstrating its extensive influence and expertise in protecting investor rights.
See More






